Anti-phospho-c-KIT (Tyr936)(K06-65BR)
FOR BULK ORDER REQUESTS PLEASE CONTACT US
Description :Rabbit Polyclonal Antibody
Species :
Tag :
Expression System:
Sequence :
Specificity :Recognizes the c-KIT protein phosphorylated at tyrosine 936
Cited Applications :IHC
Cross Reactivity :Human
Host / Isotype / Clone# :Rabbit, IgG
Immunogen :The antibody was produced against synthesized phosphopeptide derived from human c-KIT around the phosphorylation site of tyrosine 936 (H-I-Y-P-S-N).
Purification :Affinity chromatography
Stability :Store at 4oC (add 0.1% NaN3) for several months, and at -20oC for longer periods. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Sample Data :Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Anti-phospho-c-KIT (Tyr936)
Scientific Background :c-KIT is a proto-oncogene and a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). c-KIT was first identified as the cellular homolog of the feline sarcoma viral oncogene v-kit. c-KIT together with its ligand regulates growth and activation of a variety of hematopoietic and non-hematopoietic cells. Mutations in c-KIT are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Recently, deregulation of the KIT receptor TK by the prevalent activation loop mutation D816V has served as a focal point in therapeutic strategies aimed curbing neoplastic mast cell growth (2).
References :
1. Berger, S A.: Signaling pathways influencing SLF and c-kit-mediated survival and proliferation. Immunol Res. 2006;35(1-2):1-12.
2. Gotlib, J.: KIT mutations in mastocytosis and their potential as therapeutic targets. Immunol Allergy Clin North Am. 2006 Aug;26(3):575-92.
Product Sheets (By Lot #) :
Research Areas :Cancer, Cytoplasmic Tyrosine Kinases, Inflammation, Neurobiology, Cancer, Neurobiology, Inflammation, Cytoplasmic Tyrosine Kinases